bromocriptine has been researched along with Lupus Erythematosus, Systemic in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (7.14) | 18.7374 |
| 1990's | 11 (39.29) | 18.2507 |
| 2000's | 11 (39.29) | 29.6817 |
| 2010's | 4 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shoenfeld, Y; Vieira Borba, V | 1 |
| Shi, TY; Yang, YJ; Zhang, FC; Zhang, LN | 1 |
| Dongying, C; Fan, L; Hanshi, X; Hao, L; Liuqin, L; Qian, Q; Shiwen, Y; Xiuyan, Y; Yujin, Y; Zhongping, Z | 1 |
| Espinoza, LR; Jara, LJ; Medina, G; Navarro, C; Saavedra, MA; Torres-Aguilar, H; Vazquez Del Mercado, M; Vera-Lastra, O | 1 |
| He, M; Liang, LQ; Xu, HS; Yang, XY; Yao, SZ; Ye, YJ; Zhan, ZP | 1 |
| Diamond, B; Michael, D; Peeva, E; Venkatesh, J | 1 |
| Reuman, PD | 1 |
| Chuang, E; Molitch, ME | 1 |
| Angeles, U; Cruz-Cruz, P; García-Flores, A; Jara, LJ; Medina, G; Miranda-Limón, JM; Saavedra, MA | 1 |
| Ahmed, I; Sisk, C | 1 |
| Afek, A; Blank, M; Buskila, D; Goldberg, I; Kopolovic, J; Krause, I; Shoenfeld, Y; Teitelbaum, D | 1 |
| Allen, SH; Hoffman, RW; McMurray, RW; Walker, SE | 1 |
| Shoenfeld, Y | 1 |
| Allen, SH; Braun, AL; McMurray, RW; Rodriguez, F; Walker, SE | 1 |
| Walker, SE | 4 |
| Baca, V; Blanco-Favela, F; Graef, A; Lavalle, C; Ortiz, O; Ramirez-Lacayo, M | 1 |
| Allen, SH; McMurray, RW; Walker, SE; Weidensaul, D | 1 |
| Chou, CT; Huang, CM | 1 |
| Allen, SH; Houri, JM; Keisler, D; McMurray, RW; Schlechte, JA; Sharp, GC; Walker, SE | 1 |
| Alvarez-Nemegyei, J; Cobarrubias-Cobos, A; Escalante-Triay, F; Jara, LJ; Miranda, JM; Sosa-Muñoz, J | 1 |
| McMurray, RW; Nelson, W; Parker, JC; Smarr, KL; Walker, SE; Weidensaul, DN | 1 |
| Jacobson, JD; Walker, SE | 1 |
| Petro, DJ | 1 |
| Izui, S; Kanuckel, K; Keisler, D; McMurray, R; Walker, SE | 1 |
| Sahn, SA | 1 |
10 review(s) available for bromocriptine and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
Prolactin, autoimmunity, and motherhood: when should women avoid breastfeeding?
Topics: Arthritis, Rheumatoid; Autoimmunity; Breast Feeding; Bromocriptine; Female; Humans; Hyperprolactinemia; Infant; Infant Health; Infant, Newborn; Lupus Erythematosus, Systemic; Milk, Human; Prolactin; Scleroderma, Systemic | 2019 |
Prolactin as a modulator of B cell function: implications for SLE.
Topics: Animals; B-Lymphocytes; Bromocriptine; Dopamine Agonists; Humans; Hyperprolactinemia; Immune Tolerance; Lupus Erythematosus, Systemic; Mice; Prolactin | 2004 |
Prolactin: a stimulator of disease activity in systemic lupus erythematosus.
Topics: Animals; Autoimmune Diseases; Bromocriptine; Disease Models, Animal; Female; Humans; Hyperprolactinemia; Lupus Erythematosus, Systemic; Mice; Mice, Inbred Strains; Prolactin; Receptors, Prolactin | 1995 |
Immunosuppression of experimental systemic lupus erythematosus and antiphospholipid syndrome.
Topics: Adjuvants, Immunologic; Androgens; Animals; Antibodies, Anti-Idiotypic; Antiphospholipid Syndrome; Aspirin; Bone Marrow Transplantation; Bromocriptine; Cyclosporine; Disease Models, Animal; Estrogens; Ethylenes; Heparin; Hydroxyquinolines; Immunoglobulins, Intravenous; Immunosuppression Therapy; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lymphocyte Transfusion; Mice; T-Lymphocytes, Regulatory | 1994 |
Prolactin and gonadal hormones: a key relationship that may have clinical, monitoring and therapeutic implications in systemic lupus erythematosus.
Topics: Androgens; Animals; Bromocriptine; Estrogens; Female; Humans; Lupus Erythematosus, Systemic; Male; Prolactin; Rats; Rats, Inbred BUF; Rats, Inbred WF | 1993 |
Effects of prolactin in stimulating disease activity in systemic lupus erythematosus.
Topics: Bromocriptine; Hormone Antagonists; Humans; Lupus Erythematosus, Systemic; Prolactin | 1998 |
Roles of prolactin and gonadotropin-releasing hormone in rheumatic diseases.
Topics: Animals; Bromocriptine; Cytokines; Female; Gonadotropin-Releasing Hormone; Hormone Antagonists; Humans; Lupus Erythematosus, Systemic; Male; Mice; Prolactin; Rheumatic Diseases | 2000 |
Treatment of systemic lupus erythematosus with bromocriptine.
Topics: Animals; Bromocriptine; Hormone Antagonists; Humans; Lupus Erythematosus, Systemic | 2001 |
Modulation of hormones in the treatment of lupus.
Topics: Animals; Bromocriptine; Dopamine Agonists; Estrogens; Hormones; Humans; Lupus Erythematosus, Systemic; Prolactin; Testosterone | 2001 |
Immunologic diseases of the pleura.
Topics: Adult; Aged; Bromocriptine; Cardiac Surgical Procedures; Collagen Diseases; Dantrolene; Female; Granulomatosis with Polyangiitis; Heart Injuries; Humans; Immune System Diseases; Immunoblastic Lymphadenopathy; Lupus Erythematosus, Systemic; Male; Methotrexate; Methysergide; Middle Aged; Myocardial Infarction; Nitrofurantoin; Pacemaker, Artificial; Pleural Diseases; Pleural Effusion; Practolol; Procarbazine; Rheumatic Diseases; Sarcoidosis; Syndrome; Thoracic Injuries | 1985 |
6 trial(s) available for bromocriptine and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
The effects of bromocriptine on preventing postpartum flare in systemic lupus erythematosus patients from South China.
Topics: Adult; Bromocriptine; China; Dopamine Agonists; Estradiol; Female; Humans; Hyperprolactinemia; Lupus Erythematosus, Systemic; Postpartum Period; Pregnancy; Prolactin; Random Allocation; Secondary Prevention; Severity of Illness Index; Symptom Flare Up | 2015 |
[Efficacy of oral bromocriptine in protecting the postpartum systemic lupus erythematosus patients from disease relapse].
Topics: Administration, Oral; Adult; Bromocriptine; Estradiol; Female; Humans; Lupus Erythematosus, Systemic; Pregnancy; Prolactin; Puerperal Disorders | 2003 |
Bromocriptine during pregnancy in systemic lupus erythematosus: a pilot clinical trial.
Topics: Adult; Bromocriptine; Female; Humans; Lupus Erythematosus, Systemic; Mothers; Pilot Projects; Pregnancy; Pregnancy Outcome; Prolactin | 2007 |
Efficacy of bromocriptine in an open label therapeutic trial for systemic lupus erythematosus.
Topics: Adult; Bromocriptine; Female; Follow-Up Studies; Hormone Antagonists; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Prolactin; Severity of Illness Index; Treatment Outcome | 1995 |
Bromocriptine in systemic lupus erythematosus: a double-blind, randomized, placebo-controlled study.
Topics: Adult; Bromocriptine; Double-Blind Method; Female; Hormone Antagonists; Humans; Lupus Erythematosus, Systemic; Middle Aged; Pregnancy; Prolactin; Treatment Outcome | 1998 |
Mood states and disease activity in patients with systemic lupus erythematosus treated with bromocriptine.
Topics: Affect; Anger; Anxiety; Bromocriptine; Depression; Female; Health Status; Hormone Antagonists; Humans; Lupus Erythematosus, Systemic; Male; Physical Examination; Prolactin; Psychiatric Status Rating Scales; Surveys and Questionnaires | 2000 |
12 other study(ies) available for bromocriptine and Lupus Erythematosus, Systemic
| Article | Year |
|---|---|
An SLE patient with prolactinoma and recurrent granulomatous mastitis successfully treated with hydroxychloroquine and bromocriptine.
Topics: Bromocriptine; Female; Granulomatous Mastitis; Hormone Antagonists; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Pituitary Neoplasms; Prednisone; Prolactinoma; Recurrence; Young Adult | 2014 |
Prolactin has a pathogenic role in systemic lupus erythematosus.
Topics: Adaptive Immunity; Animals; Antibodies, Antinuclear; Bromocriptine; Disease Models, Animal; Dopamine Agonists; Female; Humans; Hyperprolactinemia; Immunity, Innate; Immunocompetence; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Pregnancy; Pregnancy Complications; Prolactin; Receptors, Prolactin | 2017 |
First reported pediatric case of systemic lupus erythematosus associated with prolactinoma.
Topics: Adolescent; Arthritis; Bromocriptine; Female; Hormone Antagonists; Humans; Inflammation Mediators; Lupus Erythematosus, Systemic; Pituitary Neoplasms; Prolactin; Prolactinoma; Treatment Outcome | 2004 |
Prolactin and autoimmune diseases in humans.
Topics: Aminoquinolines; Animals; Arthritis, Rheumatoid; Autoimmune Diseases; Bromocriptine; Cabergoline; Cyclosporine; Dopamine Agonists; Double-Blind Method; Drug Therapy, Combination; Ergolines; Female; Humans; Hyperprolactinemia; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Mice; Mice, Knockout; Penicillamine; Prednisone; Prolactin; Rats; Receptors, Prolactin | 2007 |
Effect of bromocriptin therapy on the electroencephalogram in chronic hepatic encephalopathy.
Topics: Adult; Bromocriptine; Electroencephalography; Evoked Potentials; Female; Hepatic Encephalopathy; Hepatitis, Chronic; Humans; Liver Function Tests; Lupus Erythematosus, Systemic | 1983 |
Bromocriptine immunomodulation of experimental SLE and primary antiphospholipid syndrome via induction of nonspecific T suppressor cells.
Topics: Animals; Antibodies, Monoclonal; Antiphospholipid Syndrome; Autoantibodies; Bromocriptine; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Lupus Erythematosus, Systemic; Lymph Nodes; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Suppressor Factors, Immunologic; T-Lymphocytes, Regulatory | 1995 |
Longstanding hyperprolactinemia associated with systemic lupus erythematosus: possible hormonal stimulation of an autoimmune disease.
Topics: Adult; Autoimmune Diseases; Bromocriptine; Female; Humans; Hyperprolactinemia; Lupus Erythematosus, Systemic; Pituitary Neoplasms; Prolactinoma; Radiography; Time Factors | 1994 |
Prolactin: an immune-stimulating peptide that regulates other immune-modulating hormones.
Topics: Androgens; Animals; Antibody Formation; Bromocriptine; Estrogens; Female; Humans; Immune System; Lupus Erythematosus, Systemic; Male; Mice; Prolactin | 1993 |
Hyperprolactinemia in systemic lupus erythematosus.
Topics: Adolescent; Adult; Arthritis, Rheumatoid; Bromocriptine; Female; Humans; Hyperprolactinemia; Lupus Erythematosus, Systemic; Male; Middle Aged | 1997 |
Bromocriptine treatment of systemic lupus erythematosus.
Topics: Animals; Autoimmunity; Bromocriptine; Disease Models, Animal; Humans; Lupus Erythematosus, Systemic; Prolactin | 2001 |
Treatment of systemic lupus erythematosus with bromocriptine.
Topics: Bromocriptine; Clinical Trials as Topic; Humans; Lupus Erythematosus, Systemic; Treatment Outcome | 2002 |
Prolactin influences autoimmune disease activity in the female B/W mouse.
Topics: Albuminuria; Animals; Antibodies, Antinuclear; Bromocriptine; Female; Immunoglobulins; Kidney Glomerulus; Lupus Erythematosus, Systemic; Mice; Mice, Mutant Strains; Prolactin; Survival Analysis; Viral Envelope Proteins | 1991 |